Peripheral Artery Disease (PAD) Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | Lisata Therapeutics, Hemostemix Inc., Anges/Mitsubishi Tanabe Pharma, Takeda

DelveInsight's "Peripheral Artery Disease Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Peripheral Artery Disease, historical and forecasted epidemiology as well as the Peripheral Artery Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Peripheral Artery Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Peripheral Artery Disease Market Forecast
https://www.delveinsight.com/sample-request/peripheral-artery-disease-pad-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Peripheral Artery Disease Market Report:
• The Peripheral Artery Disease market size was valued approximately USD 3,930 million in 2022 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In 7MM, there were over 17,245,750 diagnosed prevalent instances of PAD in 2022, and by 2032, it is anticipated that this number will rise significantly at a CAGR
• The largest diagnosed prevalence of PAD cases were in the US (9,505,662 cases), followed by the EU4, the UK (5,906,659), and Japan (1,833,429 cases) in 2022. By 2032, it is anticipated that these cases would rise in the US, EU4, the UK, and Japan
• In 2022, Germany had the greatest diagnosed prevalence of PAD among the European nations (about 2,371,290 patients), followed by Italy (1,023,681 cases). Spain, on the other hand, has the lowest diagnosed prevalence population among the EU4 countries, the UK, and the 7MM (767,393 cases).
• Key Peripheral Artery Disease Companies: Lisata Therapeutics, Hemostemix Inc., Anges/Mitsubishi Tanabe Pharma, Takeda, POLYSAN Scientific & Technological Pharma, Daiichi Sankyo, Inc., Guerbet, Lee's Pharma, TheraVasc Inc., Mercator MedSystems, Inc., Sanofi, Alvogen Korea, Sanofi, Bayer, AstraZeneca, Forest Laboratories, Bracco Diagnostics, Inc, and others
• Key Peripheral Artery Disease Therapies: Honedra, ACP-01, Collategene, Actovegin, L-arginine, edoxaban, Dotarem, Propionyl-L-carnitine Tablets, sodium nitrite, Temsirolimus, XRP0038 (NV1FGF), DP-R202, Clopidogrel (Plavix), Rivaroxaban (Xarelto, BAY59-7939), Ticagrelor, nebivolol, iopamidol, and others
• The Peripheral Artery Disease epidemiology based on gender analyzed that PAD has been identified as a male-dominant disease; however, in our analysis, the number of women suffering was higher than males
• The Peripheral Artery Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Peripheral Artery Disease pipeline products will significantly revolutionize the Peripheral Artery Disease market dynamics.

Peripheral Artery Disease Overview
Peripheral artery disease (PAD) is a typical symptom of lower and/or upper extremity arterial stenosis, which lowers arterial flow. It is generally established that PAD is linked to increased cardiovascular (CV) disease morbidity and death.

Get a Free sample for the Peripheral Artery Disease Market Report
https://www.delveinsight.com/report-store/peripheral-artery-disease-pad-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Peripheral Artery Disease Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Peripheral Artery Disease Epidemiology Segmentation:
The Peripheral Artery Disease market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Peripheral Artery Disease
• Prevalent Cases of Peripheral Artery Disease by severity
• Gender-specific Prevalence of Peripheral Artery Disease
• Diagnosed Cases of Episodic and Chronic Peripheral Artery Disease

Download the report to understand which factors are driving Peripheral Artery Disease epidemiology trends @ Peripheral Artery Disease Epidemiology Forecast
https://www.delveinsight.com/sample-request/peripheral-artery-disease-pad-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Peripheral Artery Disease Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Peripheral Artery Disease market or expected to get launched during the study period. The analysis covers Peripheral Artery Disease market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Peripheral Artery Disease Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Peripheral Artery Disease Therapies and Key Companies
• Honedra: Lisata Therapeutics
• ACP-01: Hemostemix Inc.
• Collategene: Anges/Mitsubishi Tanabe Pharma
• Actovegin: Takeda
• L-arginine: POLYSAN Scientific & Technological Pharma
• edoxaban: Daiichi Sankyo, Inc.
• Dotarem: Guerbet
• Propionyl-L-carnitine Tablets: Lee's Pharma
• sodium nitrite: TheraVasc Inc.
• Temsirolimus: Mercator MedSystems, Inc.
• XRP0038 (NV1FGF): Sanofi
• DP-R202: Alvogen Korea
• Clopidogrel (Plavix): Sanofi
• Rivaroxaban (Xarelto, BAY59-7939): Bayer
• Ticagrelor: AstraZeneca
• nebivolol: Forest Laboratories
• iopamidol: Bracco Diagnostics, Inc

Discover more about therapies set to grab major Peripheral Artery Disease market share @ Peripheral Artery Disease Treatment Market
https://www.delveinsight.com/sample-request/peripheral-artery-disease-pad-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Peripheral Artery Disease Market Strengths
• The increasing prevalence of PAD due to the increasing aging population, along with continued growth in the prevalence of diabetes, is expected to propel the treatment market in the future, adding opportunities for new pharma players

Peripheral Artery Disease Market Opportunities
• Novel technologies and improvements in current therapies are expected to improve results from endovascular therapies during the forecast period

Scope of the Peripheral Artery Disease Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Peripheral Artery Disease Companies: Lisata Therapeutics, Hemostemix Inc., Anges/Mitsubishi Tanabe Pharma, Takeda, POLYSAN Scientific & Technological Pharma, Daiichi Sankyo, Inc., Guerbet, Lee's Pharma, TheraVasc Inc., Mercator MedSystems, Inc., Sanofi, Alvogen Korea, Sanofi, Bayer, AstraZeneca, Forest Laboratories, Bracco Diagnostics, Inc, and others
• Key Peripheral Artery Disease Therapies: Honedra, ACP-01, Collategene, Actovegin, L-arginine, edoxaban, Dotarem, Propionyl-L-carnitine Tablets, sodium nitrite, Temsirolimus, XRP0038 (NV1FGF), DP-R202, Clopidogrel (Plavix), Rivaroxaban (Xarelto, BAY59-7939), Ticagrelor, nebivolol, iopamidol, and others
• Peripheral Artery Disease Therapeutic Assessment: Peripheral Artery Disease current marketed and Peripheral Artery Disease emerging therapies
• Peripheral Artery Disease Market Dynamics: Peripheral Artery Disease market drivers and Peripheral Artery Disease market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Peripheral Artery Disease Unmet Needs, KOL's views, Analyst's views, Peripheral Artery Disease Market Access and Reimbursement

To know more about Peripheral Artery Disease companies working in the treatment market, visit @ Peripheral Artery Disease Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/peripheral-artery-disease-pad-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Peripheral Artery Disease Market Report Introduction
2. Executive Summary for Peripheral Artery Disease
3. SWOT analysis of Peripheral Artery Disease
4. Peripheral Artery Disease Patient Share (%) Overview at a Glance
5. Peripheral Artery Disease Market Overview at a Glance
6. Peripheral Artery Disease Disease Background and Overview
7. Peripheral Artery Disease Epidemiology and Patient Population
8. Country-Specific Patient Population of Peripheral Artery Disease
9. Peripheral Artery Disease Current Treatment and Medical Practices
10. Peripheral Artery Disease Unmet Needs
11. Peripheral Artery Disease Emerging Therapies
12. Peripheral Artery Disease Market Outlook
13. Country-Wise Peripheral Artery Disease Market Analysis (2019-2032)
14. Peripheral Artery Disease Market Access and Reimbursement of Therapies
15. Peripheral Artery Disease Market Drivers
16. Peripheral Artery Disease Market Barriers
17. Peripheral Artery Disease Appendix
18. Peripheral Artery Disease Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:
Peripheral Artery Disease Epidemiology https://www.delveinsight.com/report-store/peripheral-artery-disease-pad-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Peripheral Artery Disease Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Peripheral Artery Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight

Multiple Myeloma Market https://www.delveinsight.com/report-store/multiple-myeloma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Multiple Myeloma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of multiple myeloma, historical and forecasted epidemiology as well as multiple myeloma market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

Monkeypox Market https://www.delveinsight.com/report-store/monkeypox-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Monkeypox Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Monkeypox, historical and forecasted epidemiology as well as the Monkeypox market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Pars Planitis Market
https://www.delveinsight.com/report-store/pars-plantis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Pars Plantis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Pars Plantis, historical and forecasted epidemiology as well as the Pars Plantis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products

Typhoid Market https://www.delveinsight.com/report-store/typhoid-fever-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Typhoid Fever Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Typhoid Fever, historical and forecasted epidemiology as well as the Typhoid Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Zika Virus Market https://www.delveinsight.com/report-store/zika-virus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Opioid Use Disorder Market https://www.delveinsight.com/report-store/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Opioid Use Disorder (OUD) - Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Opioid Use Disorder (OUD), historical and forecasted epidemiology as well as the Opioid Use Disorder (OUD) market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Recent Blog's By DelveInsight:
• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.